"The current evidence on the use of ivermectin to treat COVID-19 patients is inconclusive. Until more data is available, WHO recommends that the drug only be used within clinical trials....
Ivermectin is a broad spectrum anti-parasitic agent, included in WHO essential medicines list for several parasitic diseases...
Previous recommendations on the use of therapeutics for COVID-19:
- Strong recommendation for the use systemic corticosteroids for severe or critically ill COVID-19 patients; with a conditional recommendation against their use in patients with mild/moderate COVID-19
- Conditional recommendation against administering remdesivir in addition to usual care.
- Strong recommendation against the use of hydroxychloroquine or chloroquine for treatment of COVID-19 of any severity"
© Copyright World Health Organization (WHO), 2025. All Rights Reserved.
Copyright notice
https://www.who.int/about/policies/terms-of-use
The information in the various pages of the WHO web site is issued by the World Health Organization for general distribution. The information presented is protected under the Berne Convention for the Protection of Literature and Artistic works, under other international conventions and under national laws on copyright and neighbouring rights. Extracts of the information in the web site may be reviewed, reproduced or translated for research or private study but not for sale or for use in conjunction with commercial purposes.